BMO MSCI Genomic Innovation Index ETF - CAD Stock

ETF

ZGEN

CA05591N1033

Delayed Toronto S.E. 12:36:11 2023-12-11 EST 5-day change 1st Jan Change
18 CAD -0.06% Intraday chart for BMO MSCI Genomic Innovation Index ETF - CAD -0.28% -.--%
Dynamic Chart

Investment objective

BMO MSCI Genomic Innovation Index ETF has been designed to replicate, to the extent possible, the performance of the MSCI ACWI IMI Genomic Innovation Index, net of expenses. The Fund captures this mega trend by investing in stocks that have high exposure to innovative genomic companies. The Fund invests in and holds the Constituent Securities of the Index in the same proportion as they are reflected in the Index.
Name
Price
Change
5d. change
1st Jan change
Weight
542.1 USD +0.11%-3.95%+2.28%5.37%
66.5 USD +0.51%-2.22%-17.84%5.23%
395.8 USD +0.60%-0.12%-2.66%5.20%
107.6 USD +2.22%-1.90%-2.75%5.19%
48.44 USD +0.30%+0.37%-5.55%4.99%
103 USD +0.97%-2.43%+3.16%4.69%
221 CHF +0.48%-1.87%-9.69%4.67%
500.9 CHF -1.82%-6.17%+41.93%4.53%
117.3 USD +0.49%-7.26%-15.37%4.11%
146.4 USD +0.84%-1.62%-23.67%4.04%
See all (238)
In partnership with
TrackInsight

Description

CA05591N1033
Total Expense Ratio 0.45%
Asset Class
Sector
Size
Currency
Provider
Underlying MSCI ACWI IMI Genomic Innovation Index - CAD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2021-01-25
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2023-10-30 )

AuM (EUR) 2 M€
AuM 1M 3 M€
AuM 3 months 3 M€
AuM 6 months 3 M€
AuM 12 months 3 M€
  1. Stock Market
  2. ETF
  3. ZGEN ETF